WASHINGTON, June 24 -- Office Of The United States Trade Representative has issued a notice called: Initiation of Section 301 Investigation; Hearing; and Request for Public Comments: Germany's Persistent Underpayment for Innovative Pharmaceutical Products.
The notice was published in the Federal Register on June 24 by Jennifer Thornton, General Counsel, Office of the United States Trade Representative.
Summary: The United States Trade Representative (U.S. Trade Representative) has initiated an investigation pursuant to the Trade Act of 1974, as amended (Trade Act), with respect to Germany's persistent underpayment for innovative pharmaceutical products. The inter-agency Section 301 Committee is holding a public hearing and seeking public ...